Thu. 2 May 2024, 6:01am ET
Benzinga
Earnings, Earnings Beats, News
Aurinia Pharmaceuticals (NASDAQ:AUPH) reported quarterly losses of $(0.07) per share which beat the analyst consensus estimate of $(0.14) by 50 percent. The company reported quarterly sales of $50.300 million which beat the analyst consensus estimate of $47.453 million by 6.00 percent. This is a 46.18 percent increase over sales of $34.409 million the same period last year.